Horizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference
(firmenpresse) - DUBLIN, IRELAND -- (Marketwired) -- 06/02/16 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Jefferies 2016 Healthcare Conference at 2 p.m. EDT on June 9, 2016 in New York City, NY.
The conference presentation, which will include an update of Horizon's business, will be webcast live and may be accessed by visiting Horizon's website at .
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, rheumatology and primary care business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit . Follow on Twitter or view careers on our page.
John Thomas
Executive Vice President
Strategy & Investor Relations
Tina Ventura
Vice President
Investor Relations
Geoff Curtis
Senior Vice President
Corporate Communications
Ray Gordon
Gordon MRM
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.06.2016 - 11:00 Uhr
Sprache: Deutsch
News-ID 475255
Anzahl Zeichen: 0
contact information:
Town:
DUBLIN, IRELAND
Kategorie:
Diese Pressemitteilung wurde bisher 194 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Horizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Horizon Pharma plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
